Annexon Inc. Stock News

Annexon Inc (ANNX) shares closed this week 27.7% lower than it did at the end of last week. The stock is currently down 27.7% year-to-date, down 63.1% over the past 12 months, and down 53.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Shares traded as high as $11.95 and as low as $6.84 this week.Shares closed 78.1% below its 52-week high and 21.5% above its 52-week low.Trading volume this week was 15.4% higher than the 10-day average and 61.3% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 10.7% lower than its 5-day moving average, 30.6% lower than its 20-day moving average, and 50.0% lower than its 90-day moving average. Market Comparative Performance The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 2393.3% The company's stock price performance over the past 12 months lags the peer average by 107.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Annexon Inc (ANNX) shares closed today 10.6% higher than it did at the end of yesterday. The stock is currently down 30.1% year-to-date, down 65.4% over the past 12 months, and down 54.8% over the past five years. Today, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 0.1%. Trading Activity Shares traded as high as $12.13 and as low as $6.84 this week.Shares closed 78.9% below its 52-week high and 17.4% above its 52-week low.Trading volume this week was 298.9% higher than the 10-day average and 436.4% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 3710.2% The company's stock price performance over the past 12 months lags the peer average by 114.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Gainers: Marin Software MRIN +43%, QuinStreet (QNST) +5%, Axsome Therapeutics (AXSM) +4%, CarParts.com PRTS +3%, Curis CRIS +3%.Losers: Annexon (ANNX) -5%, Dogness (DOGZ) -4%,

Annexon Inc (ANNX) shares closed today 34.1% lower than it did at the end of yesterday. The stock is currently down 4.2% year-to-date, down 54.0% over the past 12 months, and down 38.0% over the past five years. Today, the Dow Jones Industrial Average fell 1.0%, and the S&P 500 fell 1.9%. Trading Activity Shares traded as high as $12.32 and as low as $10.88 this week.Shares closed 80.9% below its 52-week high and 33.3% below its 52-week low.Trading volume this week was 24.1% higher than the 10-day average and 19.6% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -453.0% The company's stock price performance over the past 12 months lags the peer average by 80.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Annexon Inc (ANNX) shares closed 33.3% lower than its previous 52 week low, giving the company a market cap of $422M. The stock is currently down 4.2% year-to-date, down 54.0% over the past 12 months, and down 38.0% over the past five years. This week, the Dow Jones Industrial Average rose 1.1%, and the S&P 500 rose 0.1%. Trading Activity Trading volume this week was 19.6% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -453.0% The company's stock price performance over the past 12 months lags the peer average by 80.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Investors were unimpressed by the biotech's latest clinical update.

Toward the end of trading Wednesday, the Dow traded up 0.24% to 36,711.36 while the NASDAQ fell 1.93% to 15,321.38. The S&P also fell, dropping 0.80% to 4,755.18. The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 58,040,720 cases with around 851,430 deaths. India confirmed a total of at least 35,018,350 cases and 482,550 deaths, while Brazil reported over 22,323,830 COVID-19 cases with 619,420 deaths. In total, there were at least 295,735,790 cases of COVID-19 worldwide with more than 5,476,550 deaths. Leading and Lagging Sectors Materials shares climbed 1.5% on Wednesday. Meanwhile, top gainers in the sector included GoldMining Inc. (NYSE: GLDG ), up 15% and Cleveland-Cliffs Inc. (NYSE: CLF ) up 7%. In trading on Wednesday, real estate shares fell 1.9%. Top Headline RPM International Inc. (NYSE: RPM ) reported mixed results for its second quarter on Wednesday. RPM International reported quarterly earnings of $0.79 per share, missing analysts estimates of $0.83 per share.

Investors were unimpressed by the biotech's latest clinical update.

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Annexon Announces Mixed Phase 2 Data From Huntington Disease Trial Annexon, Inc. (NASDAQ: ANNX) announ

The stock price of Annexon Inc (NASDAQ: ANNX) fell by over 35% during intraday trading today. This is why it happened.

Annexon Inc (NASDAQ: ANNX) posted interim data from its ongoing Phase 2 trial of ANX005 in patients with Huntington's disease (HD) who completed the 24-week treatment period.  Annexon is developin

Annexon Inc (ANNX) shares closed 0.4% lower than its previous 52 week low, giving the company a market cap of $458M. The stock is currently up 3.9% year-to-date, down 52.3% over the past 12 months, and down 32.8% over the past five years. This week, the Dow Jones Industrial Average rose 0.8%, and the S&P 500 rose 0.1%. Trading Activity Trading volume this week was 1.8% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 31.3% The company's stock price performance over the past 12 months lags the peer average by 75.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

ANX005 Has Been Generally Well-Tolerated and Has Shown Full Target Engagement of C1q in the CSF

BRISBANE, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classica

BRISBANE, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical